CoChat

A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: A ‘C-reactive protein’ for psychiatrists and neurologists?

Open access

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Abstract

Objective: Neurofilament light has shown promise as a biomarker for diagnosis, staging and prognosis in a wide range of neurological and neurodegenerative disorders. This study explored the utility of cerebrospinal fluid neurofilament light in distinguishing primary psychiatric disorders from neurodegenerative and neurological disorders, a common diagnostic dilemma for psychiatrists and neurologists. Methods: This cross-sectional retrospective pilot study assessed cerebrospinal fluid neurofilament light on patients referred to a tertiary neuropsychiatry service from 2009 to 2017 for diagnostic assessment of neuropsychiatric and neurocognitive symptoms, where a neurodegenerative disorder was a differential diagnosis, who received lumbar punctures as part of a comprehensive workup. The most recent gold-standard clinical consensus diagnosis was categorised into psychiatric disorder or neurodegenerative or neurological disorder. Data from healthy controls were available for comparison. Data extraction and diagnostic categorisation was blinded to neurofilament light results. Results: A total of 129 participants were included: 77 neurodegenerative or neurological disorder (mean age 57 years, including Alzheimer’s dementia, frontotemporal dementia), 31 psychiatric disorder (mean age 51 years, including schizophrenia, major depressive disorder) and 21 healthy controls (mean age 66 years). Neurofilament light was significantly higher in neurodegenerative or neurological disorder (M = 3560 pg/mL, 95% confidence intervals = [2918, 4601]) compared to psychiatric disorder (M = 949 pg/mL, 95% confidence intervals = [830, 1108]) and controls (M = 1036 pg/mL, 95% confidence intervals = [908, 1165]). Neurofilament light distinguished neurodegenerative or neurological disorder from psychiatric disorder with an area under the curve of 0.94 (95% confidence intervals = [0.89, 0.98]); a cut-off of 1332 pg/mL was associated with 87% sensitivity and 90% specificity. Conclusion: Cerebrospinal fluid neurofilament light shows promise as a diagnostic test to assist with the often challenging diagnostic dilemma of distinguishing psychiatric disorders from neurodegenerative and neurological disorders. Further studies are warranted to replicate and expand on these findings, including on plasma neurofilament light.

Overview

Integrity signals

Registry

Crossref · 10.1177/0004867419857811

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 36 references

Cited by

See all 56

Metadata

Authors
Eratne, D., Loi, S. M., Walia, N., Farrand, S., Li, Q.-X., Varghese, S., Walterfang, M., Evans, A., Mocellin, R., Dhiman, K., Gupta, V., Malpas, C. B., Collins, S., Masters, C. L., & Velakoulis, D.
Affiliations
  • The Royal Melbourne Hospital (AU)
  • The University of Melbourne (AU)
  • Delmont Private Hospital, Melbourne, VIC, Australia
  • Edith Cowan University (AU)
Corresponding author
Eratne, Dhamidhu
Venue
Australian & New Zealand Journal of Psychiatry
Published
2019-06-21
Volume
54
Issue
1
Pages
57-67
ISSN
  • 0004-8674 (ISSN-L)
  • 1440-1614
OpenAlex
W2950813440
Cited by
56
References
36
Citations by year
2026: 2 · 2025: 8 · 2024: 11 · 2023: 9 · 2022: 8 · 2021: 11 · 2020: 6 · 2019: 1
FWCI
5.18
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Australian & New Zealand Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • Edith Cowan University Research Online (Edith Cowan University) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
Funders
  • the Trisno Family Research Grant in Old Age Psychiatry
  • NorthWestern Mental Health Research Seed Grants
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Clinical Neurology › Cerebrospinal fluid and hydrocephalus
  • Health Sciences › Medicine › Clinical Neurology › Autoimmune Neurological Disorders and Treatments
Keywords
neurofilament light chain, cerebrospinal fluid biomarkers, differential diagnosis, neurodegenerative diseases, mental illness, neurological disorders, Alzheimer's dementia, frontotemporal dementia, schizophrenia, major depressive disorder, diagnostic accuracy, neuropsychiatry, lumbar puncture, biomarker cut-off values, neuroinflammation, neurodegeneration biomarkers, neuropsychiatric symptoms
MeSH terms
Aged, Alzheimer Disease, Mental Disorders, Cross-Sectional Studies, Depressive Disorder, Major, Major Depressive Disorder, Diagnosis, Differential, Female, Humans, Male, Middle Aged, Pilot Projects, Schizophrenia, Biomarkers, Neurofilament Proteins, Neurodegenerative Diseases, Frontotemporal Dementia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: A ‘C-reactive protein’ for psychiatrists and neurologists? https://app.cochat.ai/papers/10.1177/0004867419857811
The paper
Eratne, D., Loi, S. M., Walia, N., Farrand, S., Li, Q.-X., Varghese, S., Walterfang, M., Evans, A., Mocellin, R., Dhiman, K., Gupta, V., Malpas, C. B., Collins, S., Masters, C. L., & Velakoulis, D. (2020). A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: A ‘C-reactive protein’ for psychiatrists and neurologists? Australian & New Zealand Journal of Psychiatry. https://doi.org/10.1177/0004867419857811

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.